ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00246103
Recruitment Status : Completed
First Posted : October 31, 2005
Last Update Posted : February 23, 2017
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Pfizer
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2008
  Actual Study Completion Date : April 2008